None listed
Conditions
Brief summary
The purpose of this study is to try out a new imaging machine, called Integrated Magnetic Resonance Imaging Linear Accelerators (MRI-Linacs) Who is it for? You may be eligible for this study if you are aged 18 years or older and are undergoing radiation therapy for cancer at Liverpool or Macarthur Cancer Therapy Centres in Sydney. Study details All participants in this study will have two MRI-Linacs scans. The scans will be about a week apart, and involve lying still on on different positions depending on site of treatment within a confined doughnut like machine. In addition to the scans, participants will also answer questionnaires, consent to access medical records, You may require a dye injected through your viens to enhance image quality depending on the area you are having treatment to. It is hoped this research will provide information to develop new imaging procedures on the Australian MRI-Linac. The data collected will be critical in developing future MRI Linac treatments on this device.
Interventions
Eligible patients will receive two additional MRI scan sessions on the Australian MRI Linac. Each scan will take no more than one hour and separated by approximately 1 week from each other, depending on their treatment plan and other standard medical appointments they may have within the hospital. The imaging sessions will be conducted by MRI trained staff with qualified Radiation Therapist, Radiation Oncologist and Medical Physicist to assist where required. MRI gadolinium contrast may be given
Eligible patients will receive two additional MRI scan sessions on the Australian MRI Linac. Each scan will take no more than one hour and separated by approximately 1 week from each other, depending on their treatment plan and other standard medical appointments they may have within the hospital. The imaging sessions will be conducted by MRI trained staff with qualified Radiation Therapist, Radiation Oncologist and Medical Physicist to assist where required. MRI gadolinium contrast may be given at MRI simulation during the scan if clinically indicated for the patients tumour site. The dose will be according to department standard practices.
Sponsors
South Western Sydney Local Health District
Study design
Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Educational / counselling / training
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
18 years or older Have the ability to give informed consent with the clear understanding that this is a prototype cancer radiation therapy system and not a commercially available and supported system Undergoing radiotherapy treatment at Liverpool or Macarthur Cancer Therapy Centres Patients presenting with the following tumour treatment sites but not limited to: Bone metastases, Breast cancer, CNS cancer (including glioma, brain metastases), Gastrointestinal cancer (including pancreatic, liver, oesophageal and rectal cancer), Gynaecological cancer (including cervix),Head and neck cancer, Lung cancer, Prostate cancer, Renal cancer, ECOG status 0-2
Exclusion criteria
Pain or discomfort in MRI-Linac simulation positions. Patient unable to physically fit into the MRI-Linac patient treatment space or MRI Simulator Contraindication to standard radiation therapy Contraindicated for MRI as according to departmental policy. Pregnant women
Outcome results
None listed